Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets

R Liu, J Wu, H Guo, W Yao, S Li, Y Lu, Y Jia… - MedComm, 2023 - Wiley Online Library
Histones are DNA‐binding basic proteins found in chromosomes. After the histone
translation, its amino tail undergoes various modifications, such as methylation, acetylation …

Modes of interaction of KMT2 histone H3 lysine 4 methyltransferase/COMPASS complexes with chromatin

A Bochynska, J Lüscher-Firzlaff, B Lüscher - Cells, 2018 - mdpi.com
Regulation of gene expression is achieved by sequence-specific transcriptional regulators,
which convey the information that is contained in the sequence of DNA into RNA …

SMYD3 promotes the epithelial–mesenchymal transition in breast cancer

C Fenizia, C Bottino, S Corbetta, R Fittipaldi… - Nucleic acids …, 2019 - academic.oup.com
SMYD3 is a methylase previously linked to cancer cell invasion and migration. Here we
show that SMYD3 favors TGFβ-induced epithelial–mesenchymal transition (EMT) in …

SMYD3: an oncogenic driver targeting epigenetic regulation and signaling pathways

C Bottino, A Peserico, C Simone, G Caretti - Cancers, 2020 - mdpi.com
SMYD3 is a member of the SMYD lysine methylase family and plays an important role in the
methylation of various histone and non-histone targets. Aberrant SMYD3 expression …

Post-translational modifications of H2A histone variants and their role in cancer

D Corujo, M Buschbeck - Cancers, 2018 - mdpi.com
Histone variants are chromatin components that replace replication-coupled histones in a
fraction of nucleosomes and confer particular characteristics to chromatin. H2A variants …

Histone lysine methylation modification and its role in vascular calcification

YC Cao, SK Shan, B Guo, CC Li, FXZ Li… - Frontiers in …, 2022 - frontiersin.org
Histone methylation is an epigenetic change mediated by histone methyltransferase, and
has been connected to the beginning and progression of several diseases. The most …

[HTML][HTML] Histone methylation in pancreatic cancer and its clinical implications

XY Liu, CH Guo, ZY Xi, XQ Xu, QY Zhao… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Pancreatic cancer (PC) is an aggressive human cancer. Appropriate methods for the
diagnosis and treatment of PC have not been found at the genetic level, thus making …

[HTML][HTML] Overexpression of SMYD3 in ovarian cancer is associated with ovarian cancer proliferation and apoptosis via methylating H3K4 and H4K20

Y Jiang, T Lyu, X Che, N Jia, Q Li, W Feng - Journal of Cancer, 2019 - ncbi.nlm.nih.gov
Background: Epigenetic regulation has been verified as a key mechanism in tumorigenesis.
SET and MYND domain-containing protein 3 (SMYD3), a histone methyltransferase, is a …

Histone methyltransferase Smyd3 is a new regulator for vascular senescence

D Yang, G Wei, F Long, H Nie, X Tian, L Qu… - Aging …, 2020 - Wiley Online Library
Endothelial cell senescence is one of the main risk factors contributing to vascular diseases.
As increasing number of “epigenetic drugs” entering clinical trials, understanding the …

RNA Damage Responses in Cellular Homeostasis, Genome Stability, and Disease

HS Zaher, N Mosammaparast - Annual Review of Pathology …, 2024 - annualreviews.org
All cells are exposed to chemicals that can damage their nucleic acids. Cells must protect
these polymers because they code for key factors or complexes essential for life. Much of the …